MedPath

TheraVasc Inc

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain

Phase 2
Completed
Conditions
Diabetes
Interventions
First Posted Date
2015-04-09
Last Posted Date
2020-04-24
Lead Sponsor
TheraVasc Inc.
Target Recruit Count
26
Registration Number
NCT02412852
Locations
🇺🇸

Ohio Pain Clinic, Centerville, Ohio, United States

Phase IIa: Safety, PK, & Tolerability of Sodium Nitrite in Patients With Peripheral Arterial Disease-SONIC

Phase 2
Completed
Conditions
Peripheral Arterial Disease
Interventions
First Posted Date
2011-07-25
Last Posted Date
2020-04-21
Lead Sponsor
TheraVasc Inc.
Target Recruit Count
55
Registration Number
NCT01401517
Locations
🇺🇸

University of Colorado Denver Health Sciences Center, Aurora, Colorado, United States

🇺🇸

Emory University, Atlanta, Georgia, United States

🇺🇸

University of Iowa, Iowa City, Iowa, United States

and more 7 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.